MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Progression of nigrostriatal dysfunction in Parkinson’s disease: a longitudinal multimodal PET study

    K. Steidel, M. Ruppert, A. Greuel, M. Tahmasian, F. Maier, J. Hammes, T. van Eimeren, L. Timmermann, M. Tittgemeyer, A. Drzezga, D. Pedrosa, C. Eggers (Marburg, Germany)

    Objective: To investigate the longitudinal course of nigrostriatal metabolic and dopaminergic dysfunction and its impact on symptom severity in Parkinson's disease (PD) patients using a…
  • MDS Virtual Congress 2021

    Longitudinal Study of Grey Matter Nuclei in Early Parkinson’s Disease using Diffusion Kurtosis Imaging

    T. Welton, S. Hartono, Y-C. Shih, W. Lee, SL. Chong, S. Ng, N. Chia, EK. Tan, LL. Chan, L. Tan (Singapore, Singapore)

    Objective: We aimed to determine whether microstructural characteristics of key grey matter nuclei would be differentially altered between baseline and two-year timepoints in Parkinson’s disease…
  • MDS Virtual Congress 2021

    Emotional stress exacerbates parkinsonian resting tremor

    R. Blakemore, M. Pascoe, D. Myall, M. Macaskill, T. Anderson (Dunedin, New Zealand)

    Objective: To examine the role emotions may play in modulating the characteristics of parkinsonian resting tremor. Background: There is ample evidence showing cognitive stress can…
  • MDS Virtual Congress 2021

    Influence of Levodopa on Archimedes Spiral Drawings in Idiopathic Parkinson’s Disease

    L. Pillai, A. Glover, T. Virmani (Little Rock, USA)

    Objective: To study the effects of levodopa on Archimedes spiral drawings by idiopathic Parkinson’s Disease (PD) patients. Background: Handwriting difficulty can develop as an early…
  • MDS Virtual Congress 2021

    Lateralization of cochlear dysfunction as a specific biomarker of Parkinson’s disease; role for cholinergic transmission?

    R. Cerroni, A. Viziano, A. Stefani, R. Sisto (Rome, Italy)

    Objective: To understand to what extent an early cochlear dysfunction may represent an additional non-motor signature of Parkinson’s disease (PD) patients. Further, whether it may…
  • MDS Virtual Congress 2021

    Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

    S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

    Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…
  • MDS Virtual Congress 2021

    Implementing Systematic Screening and a Treatment Algorithm for Depression in Parkinson’s Disease

    C. Marras, A. Naito, J. Beck, R. de Leon, A. Allen, E. Nelson, D. Weintraub, S. Luo, S. Mantri, M. Neault (Toronto, Canada)

    Objective: Assess the feasibility and impact of systematic depression screening and management in movement disorders centers. Background: Depression is common in Parkinson’s disease (PD) and…
  • MDS Virtual Congress 2021

    Functional Constipation in Parkinson’s Disease

    S. Pavan, M. Ballal, A. Prabhu, S. Gorthi, B. Das, A. Mutreja, T. Ramamurthy, A. Pai (Manipal, India)

    Objective: To analyze and compare the Rome IV Criteria of Functional Constipation between PD and HC, with that followed by MDS-NMS, intended for determining clinical…
  • MDS Virtual Congress 2021

    A53T-SNCA-BAC transgenic mouse exhibits multiple prodromal symptoms of Parkinson’s disease: Gastrointestinal dysfunction, hyposmia and RBD-like behavior.

    T. Taguchi, M. Ikuno, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: To develop biomarkers and disease-modifying therapies for Parkinson’s disease, an animal model that recapitulates the early phase of the disease is indispensable. The aim…
  • MDS Virtual Congress 2021

    Improvement of excessive daytime sleepiness with low frequency repetitive transcranial magnetic stimulation in Parkinson’s disease: a preliminary sham-controlled study

    S. Zhuang, JJ. Wu, X. Gu, LX. Wang, XY. Zhang, CJ. Mao, J. Chen, CF. Liu (Suzhou, China)

    Objective: To explore whether repetitive transcranial magnetic stimulation (rTMS) can improve excessive daytime sleepiness (EDS) in individuals with Parkinson’s disease (PD). Background: Excessive daytime sleepiness…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley